Airship Announces Finalists for the 2024 Altitude Awards
Airship’s Altitude Awards celebrate brands across four categories critical to generating greater value from mobile-first customer experiences — acquisition, activation, value impact and unified experience
Mobile-first customer experience company Airship today announced the finalists for its 2024 Altitude Awards, recognizing brands that have created memorable digital experiences for their customers resulting in standout mobile-first value creation.
The awards celebrate outstanding achievements in customer experience across four distinct categories: acquisition, activation, value impact and unified experience.
“Over the past 15 years, Airship has equipped brands with the solutions they need to leverage the latest digital innovations in today’s mobile-driven world," said Brett Caine, CEO of Airship. "With consumer expectations at an all-time high, our customers understand this better than anyone. This year’s Altitude Awards finalists have set a new standard, delivering the seamless and connected experiences that customers expect across digital channels.”
Representing various regions across Europe, Africa, Asia and the U.S., the finalists for the 2024 Altitude Awards are:
Acquisition: Brands with exceptional strategies to drive app downloads or website visits.
- bol for “Price Alert Push as Acquisition Strategy”
- Leroy Merlin for “Conquest of New App Users”
- RHB Banking Group for “Automated Acquisition for RHB Current and Savings Account”
Activation: Brands that excel in onboarding new app users or website customers, driving ongoing engagement, opt-ins and registrations.
- Air France-KLM for “Mobile App Opt-in Game for the 2024 Olympic Games”
- Libon for “The Retrospective”
- Sally Beauty Holdings for “Sally Beauty and CosmoProf Engagement and Opt-in Growth”
Value Impact: Brands that excel in driving revenue and creating valuable app or website customer experiences.
- CIMB Group for “Empowering Simplicity with CIMB Clicks”
- Boots for “Celebrating 25 Years of the Boots Meal Deal with a Gamified Experience and Enhanced Digital Offers”
- Alaska Airlines for “Unlocking Guest Value and Revenue in the Mobile App”
Unified Experience: Brands that achieve exceptional customer engagement from cohesive, contextually connected experiences wherever customers choose to interact.
- Access Bank for “Connect and Convert: Targeted Push Communication”
- Asda for “Multichannel Rewards Round-Up”
- Synchrony Financial for “CareCredit Year in Review”
The 2024 Altitude Awards are judged by an esteemed panel of industry experts who score each entry on overall performance, amplification, innovation and degree of difficulty. 2024 Altitude Award judges include: Pietro Lambert, VP of Product Management at OneFootball; Lauren Hensley, Director of Mobile App Marketing and Lifecycle at VML; Tom Burrell, independent retention marketing consultant formerly with DAZN; and Di Wu, VP of Audience Engagement and Lifecycle Marketing at Pandora.
The winners of the 2024 Altitude Awards will be announced during a ceremony at Airship’s Mobile Leaders Forum Berlin on November 14. Mobile Leaders Forum Berlin brings together mobile experience leaders for discussions on the challenges, trends and opportunities impacting the industry. To join Airship at the event, RSVP at https://www.airship.com/events/mobile-leaders-forum-berlin-2024/. You can also watch the livestream for the awards ceremony at https://www.airship.com/events/join-the-altitude-awards-2024-ceremony-livestream/.
About Airship
Airship helps brands master mobile-first customer experiences to build lasting relationships and accelerate business growth.
Since 2009, Airship has enabled thousands of the world’s leading brands to be at the forefront of the customer experience revolution with industry-first support for push notifications, in-app messages and mobile wallet boarding passes — all now the norm in elevating experiences everywhere.
Today, the Airship Experience Platform provides an end-to-end solution for unifying experiences across apps, websites and all channels, including email, SMS, mobile wallet and more. Its no-code Experience Editor and Journeys AI solutions enable marketers and product managers to get work done in minutes instead of months, capturing more value across the entire customer lifecycle without ongoing developer support.
With the Airship Experience Platform and App Store Optimization technology and expertise, brands now have a complete set of solutions to optimize the entire customer lifecycle – from the point of discovery to loyalty – driving greater value for everyone involved.
For more information, visit www.airship.com, read our blog or follow us on X (formerly Twitter), LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030257413/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Coincheck Group N.V. to Announce Third Quarter 2025 Results on February 12, 202531.1.2025 14:30:00 CET | Press release
Coincheck Group N.V. (the “Company”) (Nasdaq: CNCK), the holding company for Coincheck, Inc, a leading Japanese crypto exchange, today announced that the Company will release its third quarter 2025 financial results on Wednesday, February 12, 2025. The Company will host a conference call to discuss third quarter 2025 financial results at 5:00 pm ET that same day. Hosting the call will be Oki Matsumoto, Executive Chairman, Gary Simanson, Chief Executive Officer, and Jason Sandberg, Chief Financial Officer. The call will be webcast live from the Company's website at www.coincheckgroup.com. A replay will be available on the Company’s investor relations website following the call. The conference call can also be accessed over the phone by dialing (877) 407-4018 or (201) 689-8471; the Conference ID is 13751285. About Coincheck Group N.V. Headquartered in the Netherlands, Coincheck Group N.V. (NASDAQ: CNCK) is a public limited liability company and the holding company for Coincheck, Inc. Coi
Datopotamab DeruxtecanRecommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer31.1.2025 14:00:00 CET | Press release
Recommendation based on TROPION-Breast01 results showing Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced risk of disease progression or death by 37% versus chemotherapy Datopotamab deruxtecan approved in the U.S. and Japan for same patient population Datopotamab deruxtecan (Dato-DXd) has been recommended for approval in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE:45680) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 202531.1.2025 12:42:00 CET | Press release
Reply has announced the opening of registrations for the ReplyHackThe Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250131992792/en/ Reply has announced the opening of registrations for the Reply Hack The Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. (Photo: Business Wire) The competition follows the format of previous events, with two parallel challenges: the Standard Edition, aimed at university
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand31.1.2025 09:00:00 CET | Press release
New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027i Demand for CT and X-Ray contrast media, used to enhance medical imaging procedures globally, is estimated to double in the next ten yearsii Investment will create additional capacity to cater for growing demand, while offering increased flexibility and resiliency for security of supply GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of the existing site will enable 25 million more patient doses per year of contrast media by the end of 2027, helping address growing global demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250130241464/en/ GE HealthCare’s contrast media manufacturing site in Cork (Photo: B
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England31.1.2025 08:00:00 CET | Press release
- Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY -- Agreement for CASGEVY in transfusion-dependent beta thalassemia (TDT) was previously reached in August 2024 - Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). The reimbursement agreement comes as the National Institute for Health and Care Excellence (NICE) issues positive guidance recommending CASGEVY’s use in the NHS. It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August. “Today is an important day for the sickle cell community who have gone too long without treatments that address the underlying cause of their devastating disease,” said Ludovic Fenaux, Senior Vice President,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom